Roche Holding stock heads into two UBS conferences on November 10
Published on 11/08/2026 at 18:00 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSTwo Investor Events Set The Agenda
- Roche lists UBS European Conference and UBS Global Healthcare Conference appearances for November 10.
- The company says 39 million patients received Roche medicines in 2025.
- The conferences put pipeline progress and investor communication in focus for the coming week.
Roche Holding stock traded at 425.78 euros on Lang & Schwarz at 5:57 p.m. CET on Sunday, November 8, 2026. Roche lists two investor appearances for Tuesday, November 10, placing the company in focus as the new trading week begins.
Two UBS Conferences On November 10
Roche's investor calendar lists the UBS European Conference in London and the UBS Global Healthcare Conference in Palm Beach for November 10. Both events are scheduled at 8:00 a.m. in their stated local time zones. The Roche investor calendar identifies the appointments as upcoming investor events.
The dual appearance gives investors two scheduled points of contact with Roche management during the week. The calendar does not specify a new earnings release or a change to the company's outlook for these meetings, so the immediate focus remains on corporate communication and the pipeline.
Scale Supports The Investment Case
Roche says 39 million patients were treated with its medicines in 2025. The company also says its diagnostics business delivered 31 billion tests to customers worldwide during the year. Those figures underline the breadth of Roche's pharmaceutical and diagnostics operations as investors assess future growth opportunities.
Roche's investor page reports 11% growth in core earnings per share at constant exchange rates in 2025, with diluted core earnings per share of 19.46 Swiss francs. The company says its two divisions are jointly focused on cancer, cardiovascular-metabolic diseases and neurological diseases.
Investors can follow the real-time quote of Roche Holding stock as the conference week develops.
Swiss equities remain the relevant market backdrop for Roche Holding stock; see the SMI market theme.
More news and analyses on Roche Holding stock.
Roche Holding Investor Snapshot
- Company: Roche Holding
- ISIN: CH1499059983
- Lang & Schwarz quote: 425.78 euros on November 8, 2026, at 5:57 p.m. CET
- 2025 patients treated: 39 million
- 2025 diagnostics tests delivered: 31 billion
- Upcoming investor events: UBS European Conference and UBS Global Healthcare Conference on November 10, 2026
